| ESVC – European Society of Veterinary Cardiology |
| ESVC-P-1 |
Kiss |
Cilostazol as medical treatment of bradycardia of cardiac origin in dogs |
| ESVC-P-2 |
Alibrandi |
Smartphone-based 6-lead ECG: a new device for electrocardiographic recording in dogs |
| ESVC-P-3 |
Costa-Rodríguez |
Correlation of serum N-terminal pro B-type natriuretic peptide with pulmonary hypertension in heartworm-infected dogs during adulticide treatment |
| ESVC-P-4 |
Kempker |
The good, the bad and the breeder - Development of genetic HCM-variants in cat populations from routine testing in the last 10 years |
| ESVC-P-6 |
Baisan |
Assessment of precordial R-peak time in dogs with left sided volume overload secondary to myxomatous mitral valve disease and dilated cardiomyopathy |
| ESVC-P-7 |
Cimerman |
Inflammatory and immune variables as predictors of survival in dogs with myxomatous mitral valve disease |
| ESVC-P-8 |
Romito |
Clinical findings and outcome in 27 cats with transient myocardial thickening |
| ESVC-P-9 |
Falcón Cordón |
Associations between thoracic radiographic changes and severity of pulmonary hypertension diagnosed via Doppler echocardiography in dogs with heartworm disease (Dirofilaria immitis). |
| ESVC-P-10 |
Georgiades |
Clinical presentation and survival in dogs with acquired atrial septal defect secondary to myxomatous mitral valve disease |
| ESVC-P-11 |
Davis |
Echocardiographic classification of dogs with aortic stenosis: potential utility of a novel staging system |
| ESVC-P-12 |
Sakarin |
Serum proteomic profiles in dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease |
| ESVC-P-13 |
Välimäki |
The impact of intravenous medetomidine and vatinoxan on echocardiographic evaluation of dogs with ACVIM stage B1 mitral valve disease |
| ESVC-P-14 |
Santana |
Percutaneous closure of patent ductus arteriosus with the Vet-PDA Occluder® device in dog |
| ESVC-P-15 |
Szatmari |
How do practicing veterinarians treat stage B and C myxomatous mitral valve degeneration in dogs? |
| ESVC-P-16 |
Van Renterghem |
Ratio of tricuspid annular plane systolic excursion on systolic pulmonary arterial pressure as a prognostic factor in canine pre-capillary pulmonary hypertension |
| ESVC-P-17 |
Panprom |
The effect of anesthesia drug on cardiac function parameters in cats |
| ESVC-P-18 |
Chang |
Aortic insufficiency in dogs and cats: A retrospective study of clinical characteristics, echocardiographic findings, and prognosis in non-infectious and non-congenital cases |
| ESVC-P-19 |
Di Grado |
Respiratory rate and breathing pattern in dogs and cats admitted to the intensive care unit at two small animal hospitals in Sweden. |
| ESVC-P-20 |
Lee |
Temporal cardiomegaly induced by non-cardiogenic respiratory distress in dogs with myxomatous mitral valve disease |
| ESVC-P-21 |
Legrand |
Association of decreased bodyweight-independent tricuspid annular plane systolic excursion (TAPSE) measured in M-mode with clinical signs of heart failure and cardiac death in dogs with pre-capillary pulmonary hypertension. |
| ESVC-P-22 |
Baisan |
Respiratory Sinus Arrhythmia Dynamics in Dogs with Various Classes of Naturally Occurring Myxomatous Mitral Valve Disease |
| ESVC-P-23 |
Sukumolanan |
Proteomics and coagulation markers in cats with asymptomatic and symptomatic hypertrophic cardiomyopathy |
| ESVC-P-24 |
Matos Rivero |
Clinical and echocardiographic findings in dogs with heartworm caval syndrome |
| ESVC-P-25 |
Iwasa |
The prognostic value of circulating cardiac and renal biomarkers in dogs with myxomatous mitral valve disease |
| SCH – Society of Comparative Hepatology |
| SCH-P-1 |
Cattaneo |
A retrospective study investigating the grade and temporal progression of feline gall bladder sludge and association with concurrent disease |
| SCH-P-2 |
Jolly-Frahija |
Biliary hamartoma: a case series in small animals |
| ESVCP – European Society of Veterinary Clinical Pathology |
| ESVCP-P-1 |
Le boedec |
Performance of predicted ionized calcium (piCa) in dogs with ambiguous prediction interval results |
| ESVCP-P-2 |
Gori |
Is the erythrocyte sedimentation rate (ESR) a reliable inflammatory marker in cats? |
| ESVCP-P-3 |
Rickards |
Frequency of healthy dogs with normal creatinine measurement and IRIS stage II categorisation using a point-of-care analyser |
| ESVCP-P-4 |
Steffensen |
Immune-modulatory effect of doxycycline on canine neutrophils: Impact on neutrophil extracellular trap formation, reactive oxygen species production and killing efficiency on Staphylococcus aureus |
| ESVNU – European Society of Veterinary Nephrology and Urology |
| ESVNU-P-1 |
Gil |
Capillary electrophoresis in urine from healthy cats: comparison with canine patterns |
| ESVNU-P-2 |
Lea |
One-step, non-surgical placement of permanent low-profile cystostomy tubes in nine dogs |
| ESVNU-P-3 |
Liu |
Comparison between urine protein-creatinine ratios of samples obtained from healthy cats at home and in hospital. |
| ESVNU-P-4 |
Bestwick |
The prevalence of disease in diagnosis-naïve older cats presented for health screening to two UK-based veterinary clinics |
| ESVNU-P-5 |
Jaturanratsamee |
Ultrasound assessments of cats associated with polycystic kidney disease caused by feline PKD1 genetic mutation |
| ESVNU-P-6 |
Schäfer |
Association of Fibroblast growth factor-23 (FGF-23) with parameters of renal dysfunction in dogs and cats |
| ESVNU-P-7 |
Daza |
Alterations in canine magnesium levels caused by Leishmania infantum-induced chronic renal disease |
| ESVNU-P-8 |
Vigouroux |
Effect of subcutaneous bypass (SUB) on proteinuria in cats with ureteral obstruction. |
| ESVNU-P-9 |
Daza |
Development of Cardiorenal Syndrome type IV (Chronic renocardiac syndrome) in cats attended to a nephrology service |
| ESCG – European Society of Comparative Gastroenterology |
| ESCG-P-1 |
Chrysovergi |
Serial evaluation of the effects of antibiotic use on the intestinal microbiome in kittens using the feline dysbiosis index |
| ESCG-P-2 |
Moraiti |
Serial measurement of serum specific pancreatic lipase and trypsin-like immunoreactivity concentrations in dogs and cats with diabetes mellitus |
| ESCG-P-3 |
Holmberg |
Comparative study of video capsule endoscopy findings in dogs with chronic enteropathy and in healthy dogs |
| ESCG-P-4 |
Mathews |
Characterization of the intestinal microbiome of dogs with inflammatory brain disease compared to dogs with non-inflammatory brain disease and healthy control dogs |
| ESCG-P-5 |
Díaz-Regañón |
Interrelation between microbiota and intraepithelial and lamina propria duodenal T-lymphocytes in dogs with inflammatory bowel disease |
| ESCG-P-6 |
Karra |
Evaluation of fecal microbiota transplantation as adjunct management of cats with chronic enteropathies in a controlled, blinded, randomized clinical trial |
| ESCG-P-7 |
Ludvigsson |
Chronic enteropathy and emotional health in dogs - a prospective comparative pilot study |
| ESCG-P-8 |
Peyron |
Overview of faecal pathogens isolated from faeces of French young cats and dogs using PCR technique over a year (2022) |
| ESCG-P-9 |
Karra |
Serial measurement of serum-specific pancreatic lipase and trypsin-like immunoreactivity concentrations in cats during treatment for chronic enteropathy |
| ESCG-P-10 |
Tang |
Relationship between 1,2-O-dilauryl-rac-glycero glutaric acid-(6’-methylresorufin) ester (DGGR) lipase activity and clinical signs in dogs with chronic gastrointestinal signs over time |
| ESCG-P-11 |
Cocci |
Prevalence of duodenal lymphangiectasia in French Bulldogs with obstructive airway syndrome undergoing endoscopic examination of the respiratory tract and upper digestive tract: retrospective study in 29 cases (2021-2022) |
| ESCG-P-12 |
Spalla |
Holter analysis in dogs with acute and chronic diarrhea |
| ESCG-P-13 |
Keller |
Psyllium husk powder increases defecation frequency and fecal score, bulk and moisture in healthy cats |
| ESCG-P-14 |
Hanifeh |
Fecal microbiota transplantation in dogs with tylosin responsive enteropathy - A proof of concept study |
| ESCG-P-15 |
Signorelli |
Characterization of underlying causes, treatment approaches, short and long-term outcome in young cats with chronic recurrent gastrointestinal signs |
| ESCG-P-16 |
Correa Lopes |
Effect of various storage conditions on bacteria viability in fecal microbiota transplantation preparations |
| ESCG-P-17 |
Méric |
Fecal proteolytic activities in dogs with chronic inflammatory enteropathies |
| ESCG-P-18 |
Smith |
Protein-losing enteropathy in Pugs: a different form of disease? |
| ESCG-P-19 |
Hawes |
Mortality rate and associated characteristics prior to hospital discharge in dogs with protein-losing enteropathy |
| ISCAID – International Society for Companion Animal Infectious Diseases |
| ISCAID-P-1 |
Breu |
Seroprevalence of toxoplasma-specific antibodies in European cats suspected of toxoplasmosis |
| ISCAID-P-2 |
Khor |
Serum cardiac troponin I as an indicator of myocarditis in dogs diagnosed with leptospirosis |
| ISCAID-P-3 |
Pavlin |
Dynamics of selected inflammatory markers during treatment of feline infectious peritonitis |
| ISCAID-P-4 |
Boontuboon |
The association between immune-mediated thrombocytopenia diagnosed by flow cytometry and canine monocytic ehrlichiosis |
| ISCAID-P-5 |
Fastrès |
Impact of DNA extraction methods and culture-independent approaches on canine lung mycobiota analysis |
| ISCAID-P-6 |
Thomsen |
Characterisation of Clinical Bleeding Diathesis, and Laboratory Haemostatic Aberrations and Survival in 180 Dogs (2005-2019) Naturally Infected with Angiostrongylus vasorum |
| ISCAID-P-8 |
Kehl |
Resistance of Leishmania infantum to allopurinol in dogs in Europe – a digital droplet PCR assay for quantifying S-adenosylmethionine synthetase (METK) gene copy number |
| ISCAID-P-10 |
Roels |
Prevalence and risk factors for Mycoplasma spp. positivity in cat blood donor units from Portugal, Spain and Belgium in 2022: retrospective study on 7573 blood donations from 4121 healthy donor cats |
| ISCAID-P-11 |
Wilczek |
A multivalent vaccine against Lyme borreliosis applied to dogs using different vaccination schedules: characterization of the humoral immune response |
| ISCAID-P-12 |
Tam |
Leptospira in dogs in Hong Kong: serology and urinary shedding |
| ISCAID-P-13 |
Murillo |
Leishmania infantum specific IL-2 production after oclacitinib and ciclosporin treatments in ex vivo stimulated canine blood |
| ISCAID-P-14 |
GONZÁLEZ |
Evaluation of complementary stem cell therapy in the treatment of kidney disease secondary to canine leishmaniasis |
| ISCAID-P-15 |
Tangmahakul |
Advantage of matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry for bacterial identification in cats with pyothorax |
| ISCAID-P-16 |
Jiménez |
The effect of oclacitinib and ciclosporin A on IL-17a production against Leishmania infantum stimulated canine blood |
| ISCAID-P-17 |
Gori |
Serum amino acid profile in canine sepsis and its relationship with survival |
| ISCAID-P-18 |
Mateu |
Comparison of Real-Time PCR and culture of bronchoalveolar lavage fluid in dogs for the detection of Bordetella bronchiseptica infection: a retrospective study of 12 cases. |
| ISCAID-P-19 |
García Rodríguez |
Co-infections and risk factors in stray cats in Gran Canaria (Spain): Dirofilaria immitis, Bartonella henselae, feline leukemia and feline immunodeficiency. |
| ESVIM – European Society of Veterinary Internal Medicine |
| ESVIM-P-1 |
García-Guasch |
Characterisation of brachycephalic obstructive airway syndrome in cats using barometric whole-body plethysmography |
| ESVIM-P-2 |
PETITPRE |
Dorsomedial nasopharyngeal masses with a benign appearance in dogs: a retrospective study of 99 cases (2019-2022). |
| ESVIM-P-3 |
Grobman |
Incidence and characterization of aerophagia in dogs using videofluoroscopic swallow studies |
| ESVIM-P-4 |
Chen |
Spectrographic analysis of lung sound for identifying visual characteristics of crackles in dogs |
| ESVIM-P-5 |
Bottero |
Clinical evaluation and endoscopic classification of gastrointestinal findings in 220 dogs with brachicephalic syndrome. |
| ESVIM-P-6 |
Geisen |
Heinz Body Formation in 13 Multimorbid Dogs following Metamizole Administration |
| ESVIM-P-7 |
Schortz |
Root cause analysis of medication-related incidents in small animal veterinary practices: An Analysis of Incident Reports |
| ESVIM-P-8 |
Jaffey |
Effects of short-term oral 25-hydroxyvitamin D supplementation on leukocyte cytokine production in healthy dogs |
| ESVIM-P-9 |
Viitanen |
Serum procalcitonin as a diagnostic biomarker in dogs with bacterial respiratory diseases |
| ESVIM-P-11 |
SU |
Clinical efficacy of feline recombinant interferon-omega as an additional agent in refractory feline chronic gingivostomatitis |
| ESVIM-P-12 |
Doulidis |
Determination of the plasma proteome of healthy dogs using Liquid Chromatography - Mass spectrometry. |
| ESVIM-P-13 |
Ostronic |
Pharmacodynamics of Standard and Low Dose Once Daily Esomeprazole in Healthy, Medium to Large Breed Dogs |
| ESVIM-P-16 |
Gaspar |
Current epidemiology and therapeutic trends of feline chronic rhinitis - a retrospective study |
| ESVIM-P-17 |
Carvalho |
Owners’ perspective about the use of mirtazapine transdermal ointment in cats – a survey-based study |
| ESVIM-P-18 |
López Bailén |
Outcome and prognostic factors in dogs diagnosed with immune-mediated thrombocytopenia in Ireland (2009-2020) |
| ESVIM-P-19 |
Pimenta da Silva |
evaluation of association between hemoparasite infection risk and blood phenotype, gender and breed in potential feline blood donors of portugal and spain |
| ESVIM-P-20 |
Álvarez |
Prevalence, age and disease associations in Yorkshire terriers with increased blood urea nitrogen |
| ESVIM-P-22 |
Mateu |
Clinical and imaging findings, bacterial isolates and antimicrobial resistance in 14 dogs with tracheal and/or bronchial collapse: a retrospective study of 14 cases. |
| ESVIM-P-23 |
Boot |
Clinical manifestations, endoscopic findings and outcome of palatine tonsil crypt foreign bodies in dogs: 7 cases (2020-2022) |
| ESVONC – European Society of Veterinary Oncology |
| ESVONC-P-1 |
Kleiter |
Implementation of an Elekta Infinity linear accelerator with advanced treatment technology |
| ESVONC-P-2 |
Marceglia |
Platelet count changes in cats with lymphoma following repeated vincristine administration. |
| ESVONC-P-3 |
Einhorn |
Outcomes and prognostic factors in canine T cell lymphoma treated with lomustine, vincristine, cyclophosphamide, and prednisone chemotherapy |
| ESVONC-P-4 |
Tena |
Incidence of elevated serum symmetric dimethylarginine in Australian dogs with multicentric large B-cell lymphoma |
| ESVONC-P-5 |
Treggiari |
Retrospective evaluation of lung lobectomy and adjuvant treatment for primary pulmonary carcinoma in dogs: a multi-institutional study |
| ESVONC-P-6 |
Hanael |
Thermographic assessment of soft tissue sarcomas in dogs. |
| ESVONC-P-7 |
Odatzoglou |
Feasibility of using flow cytometric analysis of Ki-67 expression in canine cutaneous mast cell tumours - a pilot study |
| ESVONC-P-8 |
Lollo |
Round cell tumours and the feline tarsus: a fatal attraction |
| ESVONC-P-9 |
Ramos |
Surgery and Adjuvant Electrochemotherapy Compared to Surgery Alone for Treatment of Canine Soft Tissue Sarcomas |
| ESVONC-P-10 |
Hawkes |
Evaluation of staging in 504 dogs with aggressive peripheral nodal B cell lymphoma across 16 Oncology referral centres. |
| ESVONC-P-11 |
Ghisoni |
a retrospective clinico-pathologic study of 37 dogs with urethral carcinoma (2012 - 2022) |
| ESVONC-P-12 |
Larsen |
A retrospective study of clinical outcome in response to short chemotherapy protocol for feline intermediate- and large cell lymphoma |
| ESVONC-P-13 |
Mulder |
Erythrocyte and platelet characteristics as indicators of metastasis in canine carcinomas and sarcomas |
| ESVONC-P-14 |
Del Castillo |
Is Chemotherapy Useful In Feline Mammary Tumours? |
| ESVONC-P-15 |
Garcia-de la Virgen |
Toceranib (Palladia®) as a first line therapy in macroscopic canine oral squamous cell carcinoma: a case series |
| ESVONC-P-16 |
Vázquez-Martínez |
Evaluation of the CLOP protocol as induction in canine non-indolent T-cell lymphoma |
| ESVE – European Society of Veterinary Endocrinology |
| ESVE-P-1 |
Galdhar |
Radioimmunoassay (RIA) enabled thyroid profile in healthy dogs: effect of age, sex, breed, and diet |
| ESVE-P-2 |
Bennaim |
Machine-learning as a diagnostic tool for naturally occurring hypercortisolism in dogs |
| ESVE-P-3 |
Reeves |
A prospective study to examine the natural variation of interstitial glucose levels in healthy adult dogs utilising a continuous glucose monitoring system.
|
| ESVE-P-4 |
Guse |
Signalment, clinicopathological findings, management practices and occurrence of comorbidities in cats with diabetes mellitus in Germany: prospective study of 148 cases |
| ESVE-P-5 |
Egbert |
Thyroid hormone concentrations in healthy Irish Setters and Rhodesian Ridgeback dogs: a diagnostic comparison |
| ESVE-P-6 |
Carvalho |
Interpretation of screening tests for hypercortisolism by first-opinion western european veterinary surgeons |
| ESVE-P-8 |
Stadler |
Perceptions of first-opinion veterinarians and owners in Switzerland about treatment of feline hyperthyroidism |
| ESVE-P-9 |
Kurtz |
Urinary aldosterone to creatinine ratio and fractional excretion of sodium and potassium in healthy cats, cats with primary hyperaldosteronism and cats with secondary hyperaldosteronism |
| ESVE-P-10 |
Blunschi |
The effect of treatment modality on changes in quality of life in hyperthyroid cats |
| ESVE-P-11 |
López-Gómez |
Hypercortisolism in cats in relation with diabetes mellitus: clinical and laboratory abnormalities, blood pressure and survival under trilostane treatment. |
| ESVE-P-12 |
Martineau |
Addison Detect: a machine learning predictive model web application to assess canine hypoadrenocorticism likelihood using signalment and routine bloodwork results |
| ESVE-P-13 |
Norman |
Longitudinal evaluation of blood pressure in cats treated for hyperthyroidism. |
| ESVE-P-14 |
Miceli |
Feline hypersomatotropism without concurrent diabetes mellitus: 21 cases (2014-2023) |
| ESVE-P-15 |
Rothlin Zachrisson |
Stress or success – hair cortisol concentrations in relation to cat characteristics, health and reproductive status in cats |
| ESVE-P-16 |
Del Baldo |
evaluation of urinary corticoid-to-creatinine ratio using a canine-specific chemiluminescent cortisol assay (immulite 2000) in the diagnosis of canine hypercortisolism |
| ESVE-P-17 |
Slon |
Circulating concentrations of betatrophin in dogs with diabetes mellitus |
| ESVE-P-18 |
Rey Amunategui |
Comparison of symmetric dimethylarginine, plasma aldosterone concentration, renin activity and systolic blood pressure between diabetic and non-diabetic cats with hypersomatotropism |
| ESVE-P-19 |
Rey Amunategui |
Increased insulin-like growth factor 1 concentrations in a population of non-diabetic cats with chronic kidney disease |
| ESVE-P-20 |
Allenspach |
Healthy Canine and Human Derived Pituitary Gland Organoids Exhibit Comparable Cellular Complexity and Hormone Secretion |
| ESVE-P-21 |
Strey |
Canine hypoadrenocorticism – evaluation of aldosterone concentration and thyroid autoantibodies in dogs |
| ESVE-P-22 |
Nagata |
Urinary steroid profiling using liquid chromatography-tandem mass spectrometry for the diagnosis of canine Cushing’s syndrome |
| ESVE-P-23 |
Hulsebosch |
Normal thyroid values in 3-week and 8-week-old healthy kittens |
| ESVE-P-24 |
Langlois |
Desoxycorticosterone pivalate (DOCP) pharmacodynamics in dogs with hypoadrenocorticism |
